Payers are looking to address the high costs associated with poor drug adherence across the country, an issue which racks up an estimated $300 billion bill annually.
Medication therapy management (MTM) programs, according to a HealthPayerIntelligence report, could help address the negative economic impacts of non-adherence by informing patients about strategies to help stick to their prescription.
The American Heart Association says more about 147 million patients in the U.S. fail to take their treatments as prescribed.
According to the report, an MTM program would look to develop a unique adherence strategy for individual patients, as well as monitor how the patient responds to their treatment.
To learn more about how MTM programs could save on costs and boost adherence, click here to read the full report on HealthPayerIntelligence.